Verapamil preferentially potentiates in-vitro cytotoxicity of vincristine on malignant lymphoid cells.
Malik, I A
Verapamil preferentially potentiates in-vitro cytotoxicity of vincristine on malignant lymphoid cells. [electronic resource] - Hematological oncology - 225-31 p. digital
Publication Type: Journal Article
0278-0232
10.1002/hon.2900100314 doi
Dose-Response Relationship, Drug
Drug Resistance
Drug Synergism
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Leukemia-Lymphoma, Adult T-Cell--drug therapy
Lymphocytes--drug effects
Tumor Cells, Cultured--drug effects
Verapamil--pharmacology
Vincristine--pharmacology
Verapamil preferentially potentiates in-vitro cytotoxicity of vincristine on malignant lymphoid cells. [electronic resource] - Hematological oncology - 225-31 p. digital
Publication Type: Journal Article
0278-0232
10.1002/hon.2900100314 doi
Dose-Response Relationship, Drug
Drug Resistance
Drug Synergism
Humans
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Leukemia-Lymphoma, Adult T-Cell--drug therapy
Lymphocytes--drug effects
Tumor Cells, Cultured--drug effects
Verapamil--pharmacology
Vincristine--pharmacology